Bristol-Myers Squibb announces Phase 1 results from first trial combining immune checkpoint inhibitors
2 June 2013 | By Bristol-Myers Squibb Company
Results from Study 004...
List view / Grid view
News
Roche announces final phase III study results of Avastin plus radiotherapy and chemotherapy in people with an aggressive form of brain cancer
1 June 2013 | By Roche
Final results from the phase III AVAglio study...
GSK announces late-stage clinical data for VOTRIENT® (pazopanib) following chemotherapy in women with advanced epithelial ovarian cancer
1 June 2013 | By GlaxoSmithKline
GSK announced that its Phase III clinical trial of VOTRIENT...
Amgen presents positive results from talimogene laherparepvec Phase 3 study in patients with metastatic melanoma
1 June 2013 | By Amgen
Amgen announced detailed results from a pivotal Phase 3 trial...
Superiority of afatinib* over comparator chemotherapy for patients with EGFR mutation-positive advanced lung cancer is reinforced by second Phase III study
1 June 2013 | By Boehringer Ingelheim
Data from Boehringer Ingelheim’s LUX-Lung 6 trial...
Experts call for breast cancer trials aimed at younger patients
31 May 2013 | By Cancer Research UK
A LACK of clinical trials aimed specifically at younger breast cancer patients could be partly to blame for their poorer survival rates...
INCIVO® (telaprevir) receives European Commission approval
31 May 2013 | By Daniel J Edelman Ltd
The EC has approved a new twice daily dosing of INCIVO® (telaprevir)...
Novo Nordisk files for regulatory approval of IDegLira in the EU for the treatment of type 2 diabetes
31 May 2013 | By Novo Nordisk
Novo Nordisk announced the submission to the EMA of the MAA for the approval of IDegLira...
Teva announces FDA acceptance of sNDA for a higher concentration dose of COPAXONE® given three times a week
30 May 2013 | By Teva Pharmaceutical Industries Ltd.
"We are pleased that the FDA has accepted for review our sNDA..."
Novo Nordisk supports new global commitment to fight noncommunicable diseases
30 May 2013 | By Novo Nordisk
The World Health Assembly unanimously adopted a global action plan...
GSK strengthens vaccines business with acquisition of Okairos
29 May 2013 | By GlaxoSmithKline
GSK has acquired Okairos AG, a specialist developer of vaccine platform technologies for €250 million in cash...
Syrris videos show how to access the benefits of flow chemistry
29 May 2013 | By kdm communications limited
Syrris has produced an exciting series of online videos...
Biogen Idec reinforces commitment to MS community on 5th Annual World MS Day
29 May 2013 | By Biogen Idec
Biogen Idec Corporate website dedicated to World MS Day awareness...
World MS Day: Novartis launches a new campaign to raise awareness of MS
29 May 2013 | By Novartis
Novartis is joining the global multiple sclerosis community in celebration of World MS Day...
Amgen and Astellas announce Japan alliance
29 May 2013 | By Amgen
Innovative joint venture to address unmet medical needs of patients in Japan...
